S. No |
API |
CAS. No. |
Specification |
1 |
Rifaximin |
80621-81-4 |
EP/BP |
2 |
Pinaverium Bromide |
53251-94-8 |
In-house-ICH |
3 |
Imatinib Mesylate |
220127-57-1 |
BP |
4 |
Erlotinib hydrochloride |
183319-69-9 |
In-house-ICH |
5 |
Sorafenib tosylate |
475207-59-1 |
In-house-ICH |
6 |
Lenalidomide |
191732-72-6 |
In-house-ICH |
7 |
Ticagrelor |
274693-27-5 |
In-house-ICH |
Intermediates of Erlotinib Hydrochloride |
1 |
2- Methoxy ethyl Methane Sulphonate |
16427-44-4 |
NLT 98% by GC |
2 |
3,4-Bis(2-Methoxyethoxy) benzonitrile |
80407-68-7 |
NLT 98% by HPLC |
3 |
4,5-Bis(2-Methoxyethoxy) -2-Nitro benzonitrile |
236750-65-5 |
NLT 99% by HPLC |
4 |
2-Amino-4,5-bis(2-Methoxy ethoxy) Benzonitrile |
950596-58-4 |
NLT 99% by HPLC |
5 |
Erlotinib Base |
183321-74-6 |
NLT 99% by HPLC |
Intermediates of Sorafenib Tosylate |
1 |
4-chloro-n-methylpyridine-2-carboxamide hydrochloride |
882167-77-3 |
NLT 98% by HPLC |
2 |
4-(4-amino phenoxy)- N-methylpyridine- 2-carboxamide |
284462-37-9 |
NLT 98% by HPLC |
3 |
4-[4-({[4-chloro-3-(trifluoromethyl)phenyl]carbamoyl}amino)phenoxy]-N-methylpyridine-2-carboxamide (Sorafenib Base) |
284461-73-0 |
NLT 99% by HPLC |
Intermediates of Pinavarium Bromide |
1 |
1-bromo-2-(bromo methyl)- 4,5-di methoxy benzene |
882167-77-3 |
NLT 98% by HPLC |
2 |
4-{2-[2-(6,6-Dimethyl bi cyclo [3.1.1]hept-2-yl)ethoxy]ethyl}morpholine |
38284-47-8 |
NLT 85% by GC |
3 |
Pinavarium Bromide |
53251-94-8 |
NLT 99% by HPLC |
Intermediates of Imatinib Mesylate |
1 |
Guanidine,(2-methyl-5-nitro phenyl) |
152460-07-6 |
NLT 98.5% by HPLC |
2 |
N-(2-Methyl-5-nitro phenyl)-4-(pyridin-3-yl) pyrimidin- 2-amine |
152460-09-8 |
NLT 98.5% by HPLC |
3 |
4-(bromo methyl)benzoic acid |
6232-88-8 |
NLT 98.5% by HPLC |
4 |
4-[(4-Methyl piperazin-1-yl)methyl] benzoic acid di hydrochloride |
106261-49-8 |
NLT 98.5% by HPLC |
5 |
4-Methyl-N3-[4-(pyridin-3-yl)pyrimidin-2-yl]benzene-1,3-diamine |
152460-10-1 |
NLT 98.5% by HPLC |
Intermediates of Lenalidomide |
1 |
Methyl 2-methyl-3-nitro benzoate |
59382-59-1 |
NLT 99% by HPLC |
2 |
2-Bromo methyl-3-nitro benzoic acid methyl ester |
98475-07-1 |
NLT 99% by HPLC |
3 |
3-(4-Nitro-1-oxo-1,3-di hydro iso indol-2-yl) piperidine -2,6-di one |
827026-45-9 |
NLT 99% by HPLC |